Manufacturing

Articles

Samsung will offer large-scale commercial manufacturing for drug substance and drug products to support AstraZeneca’s biologics therapeutics capabilities in the Asia-Pacific region.

AstraZeneca and Samsung Biologics to Enter into Long-Term Supply Agreement for Up to $545.6 Million

The companies will utilize Avid’s upstream and downstream process development and drug substance manufacturing services in conjunction with Argonaut’s parenteral drug product fill-finish services for the delivery of CGMP parenteral drug products for use in clinical studies.

Avid and Argonaut Enter into Manufacturing Solutions Co-Marketing Agreement

Aji Bio-Pharma launched Ajility, a flexible platform for manufacturing vaccines and therapies.

Ajinomoto Bio-Pharma Services Introduces Fast-Track Drug Product Manufacturing Platform

Leadership was announced for the US government’s Operation Warp Speed program, which aims to deliver COVID-19 vaccines, therapeutics, and diagnostics. 

The US Government Moves Forward with Plans for Accelerating Manufacturing of COVID-19 Vaccines and Treatments

WuXi Vaccines, WuXi Biologics’ joint venture with Shanghai Hile Bio-technology, has signed a 20-year vaccine manufacturing contract with a global vaccine leader for $3 billion. 

WuXi Biologics Subsidiary in $3-Billion Vaccine Manufacturing Contract

Sartorius and the German Research Center for Artificial Intelligence have established a research laboratory for AI in the biopharmaceutical industry.

Sartorius and German Research Center Collaborate on Artificial Intelligence

The expansion plans to build upon the company’s high potent drug manufacturing and development capabilities, including both clinical and commercial supply.

PCI Pharma Services Announces UK Facility Expansion

The expansion will enhance the company’s specialty drug product capabilities.

PCI Expands Illinois Pharmaceutical Manufacturing Facility

Schott and W.L. Gore introduced a prefillable, silicone-free glass syringe system, which won an award at CPhI Worldwide.

Glass Syringe System Reduces Injection Force Without Silicone

The agency has approved Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) for reducing the risk of HIV-1 infection.

Manufacturing, Drug Products